首页 › 基金 › AJU IB Investment Co., Ltd. › KYMR
AJU IB Investment Co., Ltd. 对 KYMR 的持仓历史
KYMERA THERAPEUTICS INC · 医疗保健
AJU IB Investment Co., Ltd. 在 Q1 2026 的 13F 申报中披露持有 KYMR(KYMERA THERAPEUTICS INC)19,648 股,市值约 US$1.6M,约占其申报组合的 5.36%,在其申报持仓中市值排名第 2 位。 AJU IB Investment Co., Ltd. 最近 6 个申报季度中有 6 个季度披露了 KYMR 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
AJU IB Investment Co., Ltd. 对 KYMR 的持仓演变
AJU IB Investment Co., Ltd. 于 Q4 2024 首次披露 KYMR 持仓:457,059 股(约 US$18.4M)。 该持仓在 Q3 2025 达到峰值 457,059 股,市值约 US$25.9M。 在 6 次申报中,AJU IB Investment Co., Ltd. 0 次增持、1 次减持、4 次保持不变。 最近一期申报(Q1 2026)显示持股 19,648 股、市值约 US$1.6M。 持仓曾出现大幅变动:Q4 2025 减持约 96% (随后一个季度股价上涨 7%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 457.06K | $18.39M | 新进 |
| Q1 2025 | 457.06K | $12.51M | 持有 |
| Q2 2025 | 457.06K | $19.95M | 持有 |
| Q3 2025 | 457.06K | $25.86M | 持有 |
| Q4 2025 | 19.65K | $1.53M | 减持 |
| Q1 2026 | 19.65K | $1.64M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KYMR 与 13F 数据
KYMR(KYMERA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 58 只申报持有 KYMR,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KYMR 的基金
- BAKER BROS. ADVISORS LP 8.66M 股 · $992.73M · Q2 2026
- Avoro Capital Advisors LLC 7.47M 股 · $857.13M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M 股 · $717.52M · Q2 2026
- BVF INC/IL 3.87M 股 · $444.01M · Q2 2026
- Siren, L.L.C. 2.94M 股 · $336.65M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M 股 · $326.53M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 919.23K 股 · $105.41M · Q2 2026
- Merck & Co., Inc. 772.16K 股 · $88.54M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K 股 · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 504.21K 股 · $57.81M · Q2 2026
- Rock Springs Capital Management LP 453.16K 股 · $51.96M · Q2 2026
- Boxer Capital Management, LLC 429.10K 股 · $49.20M · Q2 2026
更多关于 AJU IB Investment Co., Ltd.
常见问题
How long has AJU IB Investment Co., Ltd. held KYMR?
AJU IB Investment Co., Ltd. has disclosed KYMR holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is AJU IB Investment Co., Ltd.'s current position in KYMR?
As of Q1 2026, AJU IB Investment Co., Ltd. holds 19.65K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $1.64M, representing 5.36% of its reported portfolio and ranking #2.
Has AJU IB Investment Co., Ltd. been buying or selling KYMR?
In the latest 13F filing (Q1 2026), AJU IB Investment Co., Ltd. held unchanged its position in KYMR. The position peaked in Q3 2025 at 457.06K shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.